InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: Doktornolittle post# 3036

Friday, 12/27/2013 1:53:58 AM

Friday, December 27, 2013 1:53:58 AM

Post# of 700551
Doctor Know (relation to Doctor Who?)

You must remember, this lead investigator may sound unphased, but she is speaking with the heart of a mother and the faith of a loving daughter. If she exaggerates her findings, she would not be in her current position at UCLA. She also would be doing a disservice to her brave patients (living and passed).

The key is that L.L. is meticulous about getting to the heart of advances and missteps. She knows the lessons thus far. She has incorporated every nuance into the GBM phase three trial. The worst statistic thus far regarding anything close to her procedure is 90% OS at 1 year, 50+ at 2 years and 47% at 3 years. These are not the percentages we hope for from direct, but if these showed up from the phase 3 DCVAX-L, mankind will take a giant leap.

She stands on the shoulders of giants.... but countless others -- angels and loved ones -- will dance on the head of her scalpel and pen. The Direct trial, while conducted by V.S., will owe pure gratitude to Liau's dedication and ingenuity. I have nothing but admiration for her colleagues and friendly competitors in this field.

As of 2013, 403 patients were included in peer review studies for Dendritic cell therapy on GBM alone! http://www.ncbi.nlm.nih.gov/pubmed/23790634 It is sound science. DCVAX-L has saved birthdays, weddings, births and childhoods. DCVAX-L is not a silver bullet, it is a soldier in a tough ground game. However, it is a prelude to victory for all mankind.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News